The Role of the Body Clock in Asthma and COPD: Implication for Treatment [0.03%]
生物钟在哮喘和慢阻肺中的作用及其对治疗的启示
Karolina Krakowiak,Hannah J Durrington
Karolina Krakowiak
Asthma exhibits a marked time of day variation in symptoms, airway physiology, and airway inflammation. This is also seen in chronic obstructive pulmonary disease (COPD), but to a lesser extent. Our understanding of how physiological daily ...
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [0.03%]
吡非尼酮治疗特发性肺纤维化潜在不良事件的预防和管理的实践模式分析
Mark L Wencel,Tmirah Haselkorn,Susan L Limb et al.
Mark L Wencel et al.
Introduction: Pirfenidone is an oral antifibrotic agent approved for idiopathic pulmonary fibrosis (IPF). Real-world data on adverse event (AE) management for pirfenidone are limited. Strategies for managing potential ant...
A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients [0.03%]
评估在术后患者的标准护理中添加Aerobika振荡呼气正压装置对医疗资源利用和成本影响的真实世界证据研究
Chakkarin Burudpakdee,Aimee M Near,Huan Huang et al.
Chakkarin Burudpakdee et al.
Introduction: The aim of this real-world study was to measure the benefit of the Aerobika oscillating positive expiratory pressure (OPEP) device when added to standard of care (defined as incentive spirometry [IS]) for po...
In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance [0.03%]
体外确定高流量鼻导管治疗系统设计的主要影响因素及其对气溶胶性能的影响
Gavin Bennett,Mary Joyce,Louise Sweeney et al.
Gavin Bennett et al.
Introduction: The use of concurrent aerosol delivery during high-flow nasal therapy (HFNT) may be exploited to facilitate the delivery of a variety of prescribed medications for inhalation. Until now, a systematic approac...
Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management [0.03%]
识别关键错误：哮喘管理中的吸入剂技术问题应对措施
Sinthia Z Bosnic-Anticevich,Biljana Cvetkovski,Elizabeth A Azzi et al.
Sinthia Z Bosnic-Anticevich et al.
Medication use has always played a highly significant role in the overall management of asthma, with appropriate use being linked to good asthma control. However, while patients with asthma enjoy the 'luxury' of having medications delivered...
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002) [0.03%]
吡非尼酮在特发性肺纤维化患者中安全性的开放标签II期临床研究(研究编号：PIPF-002)
Mark H Gotfried,Carlos E Girod,Danielle Antin-Ozerkis et al.
Mark H Gotfried et al.
Introduction: PIPF-002 was a phase 2, multicenter, open-label study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) or other types of pulmonary fibrosis (PF). PIPF-002 terminated after pirfenidone beca...
Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective [0.03%]
肺动脉高压患者容量管理：肺高血压专家临床医师视角
Lillian Hansen,Marsha Burks,Martha Kingman et al.
Lillian Hansen et al.
Fluid volume management in patients with pulmonary arterial hypertension (PAH) is essential in preventing right ventricular failure. Volume overload may be caused by disease progression, indiscretion of dietary sodium and fluid intake, or m...
Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study [0.03%]
季节性用药的SQ标准化草过敏免疫治疗 tablets的实际应用：一项非介入性观察研究
Jan-Alexander Schwab,Hendrik Wolf,Jörg Schnitker et al.
Jan-Alexander Schwab et al.
Introduction: Intra-seasonal start of treatment with the SQ® grass sublingual immunotherapy (SLIT) tablet (GRAZAX®, ALK, Denmark) has been previously demonstrated to be well-tolerated. The objective of our study was to ...